Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 8, 2012, Pages 1423-1428

  Wang, Huijuan ^a,b   Zhang, Pengjun ^a,b   Chen, Weijun ^c   Feng, Dan ^a   Jia, Yanhong ^a   Xie, Li Xin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c Chinese Academy of Sciences   (China)

Author keywords

Diagnosis; miR 15a; miR 16; Sepsis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; MICRORNA 15A; MICRORNA 16; PROCALCITONIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 84867749638     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2011-0826     Document Type: Article

References (24)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The accp/sccm consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
2. Otto GP, Sossdorf M, Claus RA, Rodel J, Menge K, Reinhart K, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care 2011;15:R183.
3. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402.
4. Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and sirs than crp, il-6, or lbp. Crit Care Res Pract 2011;2011:594645.
5. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7.
6. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed rnas. Science 2001;294:853-8.
7. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-rna genes mir15 and mir16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-9.
8. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, et al. Mir-15a and mir-16 control bmi-1 expression in ovarian cancer. Cancer Res 2009;69:9090-5.
9. Bandi N, Vassella E. Mir-34a and mir-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and rb-dependent manner. Mol Cancer 2011;10:55.
10. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, Degli Uberti EC. Mir-15a and mir-16-1 down-regulation in pituitary adenomas. J Cell Physiol 2005;204:280-5.
11. Yang Y, Li X, Yang Q, Wang X, Zhou Y, Jiang T, et al. The role of microrna in human lung squamous cell carcinoma. Cancer Genet Cytogenet 2010;200:127-33.
12. Li T, Morgan MJ, Choksi S, Zhang Y, Kim YS, Liu ZG. Micrornas modulate the noncanonical transcription factor nf-kappab pathway by regulating expression of the kinase ikkalpha during macrophage differentiation. Nat Immunol 2010;11:799-805.
13. Karin M. The beginning of the end: Ikappab kinase (ikk) and nf-kappab activation. J Biol Chem 1999;274:27339-42.
14. Wang F, Wang J, Liu D, Su Y. Normalizing genes for real-time polymerase chain reaction in epithelial and nonepithelial cells of mouse small intestine. Anal Biochem 2010;399:211-7.
15. Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, et al. Serum microrna characterization identifies mir-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) 2011;120:183-93.
16. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating micrornas as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-8.
17. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of micrornas in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
18. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, et al. Microrna fingerprints identify mir-150 as a plasma prognostic marker in patients with sepsis. PloS one 2009;4:e7405.
19. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, et al. A fivemicrorna signature identified from genome-wide serum microrna expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 2011;47:784-91.
20. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microrna expression in human peripheral blood microvesicles. PloS one 2008;3:e3694.
21. Janiszewski M, Do Carmo AO, Pedro MA, Silva E, Knobel E, Laurindo FR. Platelet-derived exosomes of septic individuals possess proapoptotic nad (p) h oxidase activity: a novel vascular redox pathway. Criti Care Med 2004;32:818-25.
22. Setzer F, Oberle V, Blass M, Moller E, Russwurm S, Deigner HP, et al. Platelet-derived microvesicles induce differential gene expression in monocytic cells: a DNA microarray study. Platelets 2006;17:571-6.
23. Bartel DP. Micrornas: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
24. Yue J, Tigyi G. Conservation of mir-15a/16-1 and mir-15b/16-2 clusters. Mamm Genome 2010;21:88-94.